“Cognitive enhancement drugs only have short-term benefits and can cause significant side-effects for people with mild memory problems, according to researchers. In a new review of existing data, researchers at St. Michael’s Hospital in Toronto, Canada studied eight randomized clinical trials and three companion reports on the efficacy of four drugs in people with mild cognitive impairment. The drugs were donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), and memantine (Namenda). They found that while the drugs do have short-term benefits, they are lost after a year and a half of treatment.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Swiss solar aircraft returns from cross-US flight
Del. hospital doctor busted for selling illegal drugs for Bitcoins
Anti-gun police force robbed homeless people, resold confiscated drugs
Topless activist Phoenix Feeley goes on hunger strike in New Jersey jail
Camera Catches NY Cop Stealing Pro-Gun Yard Signs
China, Switzerland sign free trade agreement
GM, Ford and Chrysler post best U.S. sales since 2007
Why parents are more paranoid than ever
Japanese university to retract Novartis study based on fabricated data
Overstock.com CEO Discusses The Company Accepting Bitcoin
U.S. pension backstop faces $76.4B deficit; sharp premium hikes stir opposition
Colonial flags fly in Hong Kong as anger grows over Chinese rule
Flying the Government Skies
India Pledges Rupee Action as Currency Nears Fresh Low
Least Surprising News Flash Ever: Study Finds Bureaucrats Are Lazy